Tag Archives: MTH

Best Stocks To Buy For 2019

When the stock market sends a company’s share price down through no fault of the company, it can be a great time to buy. And the recent market turmoil has been tough on many businesses, regardless of whether they’re outperforming or underperforming in their industries.

Three companies that the market has walloped areApache Corporation(NYSE:APA),Magellan Midstream Partners(NYSE:MMP), andGeneral Motors(NYSE:GM). Here’s why these stocks look like bargains, and why today might be a good time to scoop up some shares.

Sometimes, the stock market hits a stock hard. That can be the best time to buy. Image source: Getty Images.

An ignored opportunity

Independent oil and gas exploration and production company Apache Corporation hasn’t been able to hit its stride since announcing a monster new oil and gas find in West Texas called “Alpine High.” The company shifted a lot of capital to developing the Alpine High field, and initial results have been encouraging. In spite of that, the stock market has bid the company’s shares lower and lower.

Best Stocks To Buy For 2019: Vishay Intertechnology, Inc.(VSH)

Advisors’ Opinion:

  • [By Max Byerly]

    Mercury Systems (NASDAQ: MRCY) and Vishay Intertechnology (NYSE:VSH) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

Best Stocks To Buy For 2019: Newfield Exploration Company(NFX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC trimmed its stake in Newfield Exploration (NYSE:NFX) by 6.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,500 shares of the energy company’s stock after selling 2,000 shares during the quarter. Fernwood Investment Management LLC’s holdings in Newfield Exploration were worth $769,000 at the end of the most recent quarter.

  • [By VantagePoint]

    Newfield Exploration Company (NYSE: NFX) just had a bearish crossover on Friday, according to the chart. The predicted 72-hour moving average crossed below the simple 10-day moving average. If Monday's price action holds, that will serve as a confirmation the negative trend. 

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Newfield Exploration Company (NYSE: NFX) which traded down nearly 5% at $23.22. The stocks 52-week range is $22.96 to $37.61. Volume was 5.2 million compared to the daily average volume of 3.3 million.

  • [By Paul Ausick]

    Newfield Exploration Co. (NYSE: NFX) traded down about 10.2% Wednesday and posted a new 52-week low of $23.10 after closing Tuesday at $25.73. The stock’s 52-week high is $40.82. Volume was approaching five times the daily average of 2.6 million shares. The independent oil & gas producer reported earnings last night.

Best Stocks To Buy For 2019: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Meritage Homes (MTH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By JJ Kinahan]

    Next week is big for housing numbers. March existing home sales figures are scheduled for  Monday and new home sales for March along with the February S&P Case-Shiller Home Price Index on Tuesday. As for homebuilders, Pulte Group, Inc. (NYSE: PHM) is scheduled to report  Q1 results Tuesday, and D.R. Horton Inc (NYSE: DHI) is scheduled to report fiscal Q2 numbers on Thursday. The industry already has seen strong Q1 results from Lennar Corporation (NYSE: LEN), and housing starts and building permits in March rose more than expected. These results, as well as those and the economic data from next week could provide clues for the industry going forward. After NVR, Inc. (NYSE: NVR) reports results this morning, Meritage Homes Corp. (NYSE: MTH) releases its Q1 results April 25. We’ll have to wait until next month for some of the other homebuilders, as well as from home improvement companies Home Depot, Inc. (NYSE: HD) and Lowe’s Companies Inc (NYSE: LOW), before we get a more complete snapshot of the housing market.

  • [By Jason Hall]

    Hall:Right, yeah. And, a lot of these areas, there’s actually an interesting thing. One of the companies we’re going to talk about, Meritage Homes (NYSE:MTH), on their latest earnings call and in their latest release, it’s not just first-time buyers,it’s not just millennials. That’s a huge secular trend, millennials moving into the home-buying market. It’s the largestsegment of the population. They’re going to be driving housing salesfor the next 20 years, potentially. But Meritage Homes also said that they’re seeing a lot of demand in their entry-level communities from retiring baby boomers who are downsizing. So,it’s creating dual demand from two opposite ends of the age demographic.

Best Stocks To Buy For 2019: Art's-Way Manufacturing Co., Inc.(ARTW)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:

Top 10 Value Stocks To Own Right Now

Investment company Harbour Capital Advisors, LLC buys Amazon.com, Alphabet, Intuit, Target, Micron Technology, Eli Lilly and Co, Citizens Financial Group, Alibaba Group Holding, Equifax, Alphabet, sells Gogo, Apple, Vanguard Total Stock Market, Broadcom, PDC Energy during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Harbour Capital Advisors, LLC. As of 2016-12-31, Harbour Capital Advisors, LLC owns 163 stocks with a total value of $135 million. These are the details of the buys and sells.

New Purchases: INTU, TGT, MU, CFG, BABA, EFX, TTM, CRTO, GPK, HDS, Added Positions: AMZN, GOOG, LLY, GOOGL, VBK, CVE, EWW, DY, V, KHC, Reduced Positions: VTI, IWF, SLB, DG, DAL, CVS, LAD, PAGP, SFM, FDX, Sold Out: GOGO, AAPL, AVGO, PDCE, T, ARMK, VWO, NXPI, FANG, WDC,

For the details of Harbour Capital Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Harbour+Capital+Advisors%2C+LLC

These are the top 5 holdings of Harbour Capital Advisors, LLCChevron Corp (CVX) – 57,856 shares, 5.04% of the total portfolio. Shares reduced by 0.69%iShares Russell 1000 Value (IWD) – 43,240 shares, 3.58% of the total portfolio. Shares reduced by 0.8%iShares Russell 1000 Growth (IWF) – 37,853 shares, 2.94% of the total portfolio. Shares reduced by 15.04%JPMorgan Chase & Co (JPM) – 31,329 shares, 2% of the total portfolio. Shares reduced by 1.14%iShares Russell 1000 (IWB) – 20,025 shares, 1.84% of the total portfolio. Shares reduced by 1.96%New Purchase: Intuit Inc (INTU)

Harbour Capital Advisors, LLC initiated holdings in Intuit Inc. The purchase prices were between $105.28 and $118.39, with an estimated average price of $111.97. The stock is now traded at around $123.18. The impact to the portfolio due to this purchase was 0.34%. The holdings were 4,036 shares as of 2016-12-31.

Top 10 Value Stocks To Own Right Now: The ExOne Company(XONE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) rose by 1.6% to 2.38 million shares. About 22.1% of the company’s shareswere short. ExOne’s share price fell by nearly 13% in the two weeks. The stock’s 52-week range is $6.60 to $16.15, and shares closed at $11.11 on Friday, down about 0.7% for the day. Days to cover fell from 17 to 13.

  • [By Peter Graham]

    A long term performance chart shows Voxeljet AGalong with other small cap 3D printing stocks like ExOne Co (NASDAQ: XONE), 3D Systems Corporation (NYSE: DDD) and Stratasys, Ltd (NASDAQ: SSYS) all peaking around 2013-2014, but also showing some signs of life in recent months:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) fell by 1.7% to 1.86 million shares. About 19.8% of the company’s shares were short. ExOne’s share price jumped by about 14.2% in the period. The stock’s 52-week range is $6.72 to $14.43, and shares closed at $10.39 on Wednesday, up about 1.6% for the day. Days to cover rose from eight to 11.

  • [By Peter Graham]

    A long term performance chart shows shares of Stratasys, Ltd along with other small cap 3D printing stocks like 3D Systems Corporation (NYSE: DDD), ExOne Co (NASDAQ: XONE)and Voxeljet AG (NYSE: VJET) all peaking a few years and all showing some signs of stabilization over the past year:

Top 10 Value Stocks To Own Right Now: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

Top 10 Value Stocks To Own Right Now: Transdigm Group Incorporated(TDG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    TransDigm Group (TDG) soared to the top of the S&P 500 today after beating earnings and sales forecasts.

    Agence France-Presse/Getty Images

    TransDigm gained 6.5% to $245.88 today, while the S&P 500 finished little changed at2,293.08.

    TransDigm reported a profit of $2.57, beating forecasts for$2.47, on sales of $814 million, topping the Street consensus for $804.5 million.

    TransDigm’s market capitalization rose to $13.1 billion today from $12.3 billion yesterday.

  • [By Mitchell Clark]

     This firm is not a household name. This Cleveland-based company, in the aerospace parts business, has approximately $12.0 billion in market capitalization on the stock market.

    TransDigm Group Incorporated (NYSE:TDG) doesn’t pay a regular dividend, but often pays out one-time, special dividends. In the past, they’ve been pretty hefty.

    Selling pumps, motors, power systems, and basically anything you can image that’s part of an aircraft, TDG’s been growing its financial results at a good clip.

  • [By Ben Levisohn]

    TransDigm Group (TDG) tumbled to the bottom of the S&P 500 today after Citron Research doubled down on its assertion that the company is a manufacturing version of Valeant Pharmaceuticals International (VRX).

    Agence France-Presse/Getty Images

    TransDigm Groupdropped 4.2% to $231.37, while the S&P 500 rose 0.3% to 2,372.60.

    From Citron’s report on TransDigm:

    Citron predicts that after this report makes its rounds, TransDigms (NYSE:TDG) days of exploiting and deceiving the Federal Government are numbered.

    Valeant Pharmaceuticals has recently hit prices lower than some ever thought was imaginable. As Citron observes today, at $12 per share, that stock is down over 95% from its highs just months prior to Citrons reporting on Philidor. The questions then turn to: How did so many smart people get it so wrong? and When could this possibly happen again?”

    While we are sure there will be many books written on these questions, we can narrow it down to a small checklist. The smart money got Valeant wrong by:

    Disregarding a roiling political climate disrupting “business as
    usual” Underestimating the financial frailty of a roll up Discounting the dangers of a small customer base (PBMs) Putting too much trust in the companys CEO…

    All points in the above checklist apply directly to TransDigm.

    TransDigm Group’s market capitalization fell to $12.2 billion today from $12.8 billion yesterday. It reported net income of $583 million on sales of $3.2 billion in 2016.

  • [By Ben Levisohn]

    TransDigm (TDG) sunk to the bottom of the S&P 500 today after its earnings topped the Street consensus but its guidance disappointed.

    Shares of TransDigm fell 7.1% to $$252.96 today, while the S&P 500 finished little changed.

    TransDigm reported a profit of $3.29 a share, better than the $3.20 expect by analysts, on sales of$875.2 million, below forecasts for $884.26 million. Worse still, the airplane-part manufacturer said it would earn $11.84 to $12.12 a share in fiscal 2017, below forecasts for$12.80.

    TransDigm’s market cap fell to $13.5 billion today, from $14.5 billion on Friday.

  • [By Lee Jackson]

    Transdigm Group Inc. (NYSE: TDG) had a director at the company step in and buy stock in a big way last week. That director purchased a total of 91,000 shares of the stock at prices ranging from $247.16 to $247.89. The total for the trade came in near $22.7 million.The company designs, produces and supplies aircraft components in the United States. Its stock closed trading last Friday at $251.488.

  • [By Lee Jackson]

    Warren Buffett and Berkshire Hathaway were big buyers this week, as they added shares of aircraft components maker Transdigm Group Inc. (NYSE: TDG), forwhich they also serve as a director. Berkshire Hathaway bought 104,967 shares of the stock at prices that ranged from $231.18 to $234.40 per share. The total for the trade came in at a massive $25 million. The shares closed trading last Friday at $240.05, so the timing looks good. The 52-week trading range for the stock is $214.65 to $294.38. The Wall Street consensus price target is pegged at $295.24.

Top 10 Value Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 25% since Sept. 1. The S&P is up a 15% over the same timeframe.

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By Ben Levisohn]

    Shares of ExxonMobil have ticked up 0.1% to $81.89 at 3:17 p.m. today, while Chevron has risen 0.5% to $108.62. The Energy Select Sector SPDR (XLE) has advanced 0.1% to $69.31.

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

Top 10 Value Stocks To Own Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Peter Graham]

    Online travel stock Tripadvisor Inc (NASDAQ: TRIP) reportedQ1 2017 earnings after the market closed on Tuesday with shares up in afterhours /premarket trading. Q1 revenue rose 6% (or 7% on a constant currency basis) to $372 million as hotel revenue grew 4% to $314 million and non-hotel revenue rose 18% to $58 million.Net income was $13 million versus $29 million. Key business metrics cited in the earnings report included:

  • [By Peter Graham]

    A long term performance chart shows Angie’s List basically back to breakeven while other online review stocks like small cap Yelp Inc (NYSE: YELP) and mid cap Tripadvisor Inc (NASDAQ: TRIP) have performed a bit better with mid capacquirer IAC has been a better performer:

  • [By Ben Levisohn]

    TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today, a reversal of yesterday’s big gain following the news thatExpedia (EXPE) would participate in its Instant Booking program.

    Agence France-Presse/Getty Images

    TripAdvisordropped 5.1% to $46.28 today, while the S&P 500 declined 0.3% to 2,265.18.

    In a note published yesterday, SunTrust Robinson Humphrey’s Rodney Hull and team called the announcement a “positive for [the] platform” but worried about the fact that “shopper growth and monetization have been muted.” They explain:

    Ultimately, TripAdvisor is seeking to improve its revenue per shopper which trails its OTA peers who earn 4-5x more per shopper by driving booking and repeat booking activity on their sites. On a positive note, TripAdvisor stated that US trends improved through the third quarter and that transaction revenue and rev/shopper turned positive in October. Further, green shoots in app bookings and vaulted credit cards are noteworthy. However, the dual headwinds of mobile and the IB transition continue to negatively impact financials as well as the “flywheel” for shopper growth and visibility into improving growth remains limited, aside from easing comps. We have a positive view of the company’s longer-term monetization opportunity, but we await further signs of inflection in growth and profitability, which may follow a larger ad campaign. Recall, the company reduced its margin outlook for 2017 on the 3Q call as it will likely look to increase paid marketing spend and invest revenue per shopper gains to restart the flywheel

    TripAdvisor’s market capitalization fell to $6.7 billion today from $7.1 billion yesterday. It reported net income of $198 million on sales of $1.5 billion in 2015.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Value Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Top 10 Value Stocks To Own Right Now: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.

    The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.

    For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.

    Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:

    Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.

    The shares are down 3.3% to $99.31 in recent trading.

Top 10 Value Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Value Stocks To Own Right Now: Paychex Inc.(PAYX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter on Wednesday.

    Paychex posted Q3 earnings of $0.56 per share on revenue of $795.8 million. However, analysts were expecting earnings of $0.54 per share on revenue of $799.0 million.

  • [By Monica Gerson]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Paychex, Inc. (NASDAQ: PAYX) is estimated to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Paychex shares rose 1.10 percent to close at $56.14 on Wednesday.
    Wall Street expects Micron Technology, Inc. (NASDAQ: MU) to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. Micron shares rose 0.76 percent to $13.29 in after-hours trading.
    Pier 1 Imports Inc (NYSE: PIR) reported a wider-than-expected loss for its first quarter and issued a weak outlook. Pier 1 Imports shares dropped 6.07 percent to $5.11 in the after-hours trading session.
    Analysts are expecting McCormick & Company, Incorporated (NYSE: MKC) to have earned $0.74 per share on revenue of $1.06 billion in the latest quarter. McCormick shares fell 0.59 percent to $102.10 in after-hours trading.

    Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion.
    ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion.
    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million.
    Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion.
    McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion.
    Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share.
    Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million.
    Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million.
    Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Monica Gerson]

    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.50 per share on revenue of $751.20 million.

    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.26 per share on revenue of $362.62 million.

  • [By WWW.THESTREET.COM]

    Wednesday brings earnings from General Mills (GIS) , which will likely be disappointing, Paychex (PAYX) , which will likely be good, and an analyst meeting from Cisco Systems (CSCO) , which needs to show investors it still has more growth ahead.

Top 10 Value Stocks To Own Right Now: Grow Solutions Holdings, Inc. (GRSO)

Advisors’ Opinion:

  • [By Javier Hasse]

    Grow Solutions Holdings Inc (OTC: GRSO) acquired Keys Organic and Hydroponic Supply.

    "What we are starting to see here is aggregation in the highly-fragmented hydroponic and grow supply industry. Most of these stores, including Keys Organic and Hydroponic Supply, are typically local or regional — This results in a very fragmented market."
    "We saw this [aggregation] happen with grocery stores, the finance industry, auto dealerships — Bigger names come in. So, instead of Bob's Ford Motor Company (NYSE: F) Dealership or Fred'sGeneral Motors Company (NYSE: GM) outlet, you'll get companies likeAutoNation, Inc. (NYSE: AN) come in, put them under a single brand, consolidate HR and other expenses to develop economies of scale and really help additional bottom line."
    “Another way to look at it is, there's coffee shops all around the world, but there's also Starbucks Corporation (NASDAQ: SBUX), which started locally […] and developed really organically. But, they could just buy the local coffee shop, redesign it to the Starbucks brand, put their name on it… Now they have the distribution network, the backing of Starbucks, Starbucks will take care of their HR, their payroll — It's a more synergistic approach and a really value-add if they can consolidate any level of scale.”

    Elev8 Brands Inc (OTC: VATE) acquired O2 Breathe, LLC, a company supplying portable oxygen bars and aromatherapy inhalers.

Top Performing Stocks To Invest In Right Now

Source: ThinkstockDecember 28, 2017: The S&P 500 closed up 0.2% at 2,687.45. The DJIA closed up 0.25% at 24,836.54. Separately, the Nasdaq wasup 0.2%at 6,950.16.

Thursday was a relatively positive day for the markets, albeit a slow one. While the exchanges did not hit new highs they were easily within striking distance. Crude oil recovered slightly on the day, and is less than a dollar away from $60. The S&P 500 sectors were nearly all positive. The best performing sectors were utilities and real estate, up 0.5% and 0.6%, respectively. The worst performing sector was consumer staples down 0.2%.

Crude oil was up 0.4% at $59.88.

Gold was up 0.4% at $1,297.10.

The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Monster Beverage Corp. (NASDAQ: MNST) which traded down about 2% at $62.99. The stocks 52-week range is $41.02 to $64.79. Volume was just over 1 million versus the daily average of about 2 million shares.

Top Performing Stocks To Invest In Right Now: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    While a new year has been ushered in, it is clear PayPal’s philosophy has not changed. Last week, PayPal entered into another major agreement, this time with credit card issuerDiscover Financial Services (NYSE:DFS).

  • [By JACK HOUGH]

    Like CVS, Discover has trounced the broad market over the long term but sold off recently. It’s down more than 15% this year. Costs rose early in the year in part due to one-time expenses related to anti-money-laundering efforts and other regulatory concerns. Analysts predict an offsetting decline in expenses next year. Don’t confuse Discover with a company that’s primarily in the business of running a credit-card network, like Visa (V) and MasterCard (MA). It’s basically a credit-card lender, like Capital One Financial (COF), that runs its own network to gain a competitive advantage.

    By saving on network fees, Discover can offer attractive card rewards, including a popular cash-back program. Any card lender can offer cash back, of course, but being too aggressive risks hurting margins. Discover has grown its portfolio of credit-card loans much faster than big banks have in recent years. And it has done so with industry-leading returns on capital. Rising growth could be on the way. Early this year, Discover went on a marketing spree. Last quarter, it reported its best card growth since 2007. Historically, new-card growth and loan growth have been closely correlated. In a November note to investors, Morgan Stanley analyst Cheryl Pate predicted accelerating loan growth within six months. Meanwhile, defaults remain low. Shares sell for less than 10 times projected earnings for the next four quarters, down from 12 times at the end of last year. They could rise 20% on a combination of earnings growth and a valuation rebound. The dividend yield is 2%. 

  • [By Ben Levisohn]

    We get the bull case.American Express is a blue-chip Dow component with an iconic global brand. It generates >30% returns on tangible, but it is trading well below its historical multiple and has underperformed post the election. Costco is now in the rearview mirror, and the string of negative surprises that have weighed on the stock are now poised to abate and position the company to start surprising positively. With Capital One Financial (COF), Discover Financial Services (DFS), and Synchrony Financial (SYF) all trading near their historical peaks, some have concluded thatAmerican Express is headed back to its historical high above $90. While this thought process may sound logical, we believe it only works in a world where generalists are steering the ship, and view it as highly susceptible to unraveling when negative revisions hit. American Express is not the business it once was, it doesnt have the same earnings power, and, in our view, it doesnt deserve to trade near its historical valuation.

Top Performing Stocks To Invest In Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top Performing Stocks To Invest In Right Now: Arris Group Inc(ARRS)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    Based in San Francisco, Dedrone also has the backing of Dominic Orr, CEO of Aruba Networks, a unit of Hewlett Packard Enterprise Inc. (NYSE: HPE); and Selina Lo, CEO of Ruckus Wireless, a unit of Arris International PLC (Nasdaq: ARRS).

Top Performing Stocks To Invest In Right Now: Blue Buffalo Pet Products, Inc.(BUFF)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report formid cap pet stock Blue Buffalo Pet Products Inc (NASDAQ: BUFF)is scheduled for after the market closes onThursday (November 10th) with earnings beating expectations the last time around.

  • [By Monica Gerson] Related BUFF Mid-Afternoon Market Update: Crude Oil Rises 3.5%; Zagg Shares Fall Following Weak Q4 Results Mid-Day Market Update: Blue Buffalo Pet Products Rises Following Strong Q4 Results; Ocean Rig UDW Shares Slide Blue Buffalo Pet Products' (BUFF) CEO Kurt Schmidt on Q1 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related ARMK Earnings Scheduled For May 11, 2016 Earnings Scheduled For February 10, 2016

    Some of the stocks that may grab investor focus today are:

  • [By Peter Graham]

    Mid cap pet stock Blue Buffalo Pet Products Inc (NASDAQ: BUFF)reportedQ1 2017 earnings after the market closed Tuesday.Net sales increased 7.9% to $302.0 million driven primarily by volume growth. Net sales of Dry Foods increased 6.4% to $245.2 million while net sales of Wet Foods, Treats and Other Products increased15.1% to $56.8 million. Net income increased 18.1% to $44.1 million and cash and cash equivalents were $338.2 million as of March31, 2017 versus $292.7 million as of December31, 2016. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express giving a steady performance before jolting higher this yearand pet stock peerCentral Garden & Pet Co (NASDAQ: CENT) also being agood performer while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peerCentral Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

Top Performing Stocks To Invest In Right Now: North American Energy Partners, Inc.(NOA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.

Best Warren Buffett Stocks To Buy Right Now

Since 2014 Hershey (NYSE:HSY) has been struggling a lot with its foreign operations. This has been due to the facts that the general business environment has been rather weak in foreign countries where Hershey is operating, that a strong dollar has hurt the sales and especially that the Chinese market has proved to be much more difficult than expected.

One other thing that I am even more worried about is the way the current management at Hershey is using adjusted earnings in its earnings releases. I do not know about the rest of the investors, but at least for me, when management is constantly talking about adjusted earnings instead of actual earnings, it is a warning sign. I can fully understand one-time business costs, such as transactions costs related to a major acquisition. In that type of a situation it is perfectly fine to use adjusted earnings because they give more visibility about the true earnings power of a company. However, when a company starts to constantly categorize regular annual costs as one-time costs, like Hershey is doing with business realignment costs, you should be very worried. In the case of Hershey, I would consider the business realignment costs as regular costs as they have been there for several years. This is a bit like when Warren Buffett is recommending that investors walk away if management is constantly referring to EBIT figures.

Best Warren Buffett Stocks To Buy Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

Best Warren Buffett Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Best Warren Buffett Stocks To Buy Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Best Warren Buffett Stocks To Buy Right Now: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Natural gas just claimed another victory over clean coal, as Southern Co. (NYSE: SO) announced on June 28 it’s converting its failed $7.1 billion clean coal power plant into a natural gas-fired facility.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 2.9% Wednesday and posted a new 52-week low of $45.81 after closing Tuesday at $47.20. The 52-week high is $53.51. Volume was about 5.5 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Wednesday.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.7% Friday and posted a new 52-week low of $44.46 after closing Thursday at $45.25. The 52-week high is $53.51. Volume was over 6 million, about 20% above the daily average of around 4.8 million shares. The company was dropped from Neutral to Sell at Goldman Sachs on Thursday.

Best Warren Buffett Stocks To Buy Right Now: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

Best Warren Buffett Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

Top 10 Low Price Stocks To Own Right Now

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top 10 Low Price Stocks To Own Right Now: LKQ Corporation(LKQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

Top 10 Low Price Stocks To Own Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By William Patalon III]

    In a Private Briefing report in late July, we told you that tiny biotech Inovio Pharmaceuticals Inc. (Nasdaq: INO) had dosed its first patient in a Phase I clinical study to evaluate its synthetic vaccine for the Zika virus.

  • [By Lisa Levin]

    Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were also up, gaining 24 percent to $8.84 following announcement of a clinical study for a HIV vaccine that had nearly 100 percent immune response.

  • [By Ben Levisohn]

    Shares of Inovio Pharmaceuticals(INO) are climbing today after the biotech company announced that it would begin testing a Zika vaccine in Puerto Rico. Maxim’sJason McCarthy andJason Kolbert have the details:

    CREDIT: Alex Wild Published Credit: Alex Wild Alex Wild

    Inovio announced the initiation of a small clinical study (N=160) of its Zika vaccine, GLS-5700 (being developed with GeneOne Life Sciences), in Puerto Rico. It is estimated by the CDC that the Zika virus could infect more than 25% of the population of Puerto Rico by YE16.The study will evaluate safety, immunogenicity and early signs of efficacy in preventing Zika infection. Data are expected in 2017, and if positive, Inovio will discuss with regulators the best path forward.

    In addition, the phase I study of GLS-5700 (N=40) in the U.S. and Canada, which is the first in-human Zika vaccine study, is now fully enrolled. Data evaluating safety and immunogenicity are expected by YE16.

    Conclusion. With the Zika virus spreading, including to the U.S., there remains an urgent need for a vaccine. Inovio continues to demonstrate that the company’s DNA-based vaccine approach is safe and can rapidly transition to human studies.

    Shares of Inovio Pharmaceuticalshave gained 4.3% to $9.24 at 2:50 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.3% to $284.29.

Top 10 Low Price Stocks To Own Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Chris Lange]

    Merck & Co., Inc. (NYSE: MRK) is expected to share its latest quarterly earnings on Friday. The consensus estimates are$0.87 in EPS on $9.74 billion in revenue. Shares were at $62.63 at Fridays close, in a 52-week range of $57.18 to $66.80. The consensus price target is $69.70.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) dropped about 6.6% Monday to post a new 52-week low of $54.41 after closing at $58.24 on Friday. The stock’s 52-week high is $66.80. Volume of around 32 million was about four times the daily average. The drug maker said it had withdrawn its application for approval of a key lung cancer treatment.

  • [By Ben Levisohn]

    Jefferies analyst Jeffrey Holford and aren’t feeling too upbeat about pharmaceutical stocks in 2017, noting that politics, as well as pharmacy benefit managers, could put downward pressure on pricing. Then there are the weakening fundamentals. As a result, they cut their rating Merck (MRK) to Underperform from Hold…

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Ben Levisohn]

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 0.36% at $56.54. The stock’s 52-week range is $53.63 to $66.80. Volume was about 70% below the daily average of around 11.7 million shares. The company had no specific news.

Top 10 Low Price Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By Craig Jones]

    On CNBC's Trading Nation, Andrew Keene of AlphaShark suggested a bearish options strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He noticed that Energy Select Sector SPDR (ETF) broke out above its resistance, but he thinks it's a fake breakout, which is not going to hold. Keene wants to use options to fade the rally. He wants to buy the March 70/67 put spread for $1. The trade breaks even at $69 or 5.19 percent lower and it can maximally make a profit of $2 if the stock drops to $67 or lower.

Top 10 Low Price Stocks To Own Right Now: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top 10 Low Price Stocks To Own Right Now: Albemarle Corporation(ALB)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By Ben Levisohn]

    Albemarle (ALB) soared to the top of the S&P 500 today after beating fourth-quarter earnings and revenue forecasts.

    S. MARTIN/AFP/Getty Images

    Albemarle gained 9.8% to $101.50, while the S&P 500 dipped 0.3% to 2,363.64.

    Baird’s Ben Kallo and team liked what they saw from Albemarle:

    Reiterate Outperform rating after results beat and guidance exceeded estimates. ALB continues to see strong Lithium demand and pricing, expects Refining Solutions to return to earnings growth in 2017 driven by stronger HPC demand, and bolstered its balance sheet with the sale of Surface Treatment. Additionally, although Bromine is expected to be flat y/y, the segment should generate strong FCF for Lithium investment. We expect shares to trade higher as ALB continues to separate itself from specialty chemical comps with leading market positions and strong revenue growth.

    Albemarle’s market capitalization rose to $11.4 billion today from $10.4 billion yesterday.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Low Price Stocks To Own Right Now: Wabash National Corporation(WNC)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of Wabash National Corporation (NYSE:WNC) jumped 10.1% in April, according to data provided by S&P Global Market Intelligence, after the company reported its first-quarter 2017 results.

Top 10 Low Price Stocks To Own Right Now: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Jabil Circuit, Inc. (NYSE: JBL) to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion. Jabil Circuit shares fell 0.83 percent to close at $21.42 yesterday.

  • [By Monica Gerson]

    Jabil Circuit, Inc. (NYSE: JBL) is projected to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion.

    Guess?, Inc. (NYSE: GES) is expected to post its quarterly earnings at $0.58 per share on revenue of $657.59 million.

  • [By Chris Lange]

    And Jabil Inc. (NYSE: JBL) will report its fiscal first-quarter results on Thursday. The consensus estimates are EPS of $0.79 and revenue of $5.5 billion. Shares traded at $27.88 on Friday’s close, in a 52-week range of $21.31 to $31.70. The consensus price target is $32.23.

Top 10 Low Price Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Low Price Stocks To Own Right Now: Unilife Corporation(UNIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unilife Corp (NASDAQ: UNIS) shares dropped 76 percent to $0.295. Unilife reduced its workforce by 51 employees and expects to record charge of $0.6 million.